Facebook
Twitter
LinkedIn
ForwardSummit of the Americas on Immunotherapies for Hematologic Malignancies, Third Annual
Symposium Guide
Friday, April 8, 2022
Claim CME Credit
MOBILE USERS: Click on the button below and enter the six-digit code provided at the symposium to receive your credit.
DESKTOP USERS: Scan the QR code shown below with your mobile phone, and enter the six-digit code provided at the symposium to receive your credit.
Evaluation
Click on the button below to complete today's evaluation. The evaluation will be available at the conclusion of today's program.
Hotel Map
Presentations
Session Title
Download
8:45 - 9:15 a.m.
Treatment Approach for High-Risk Acute Myeloid Leukemia in 2022
Richard Stone, M.D.
Treatment Approach for High-Risk Acute Myeloid Leukemia in 2022
Richard Stone, M.D.
9:15 - 9:45 a.m.
Overcoming Resistance to Targeted Therapies in Acute Myeloid Leukemia
Eytan Stein, M.D.
Overcoming Resistance to Targeted Therapies in Acute Myeloid Leukemia
Eytan Stein, M.D.
9:45 - 10:15 a.m.
Myelofibrosis: Current and Emerging Treatments
Raajit Rampal, M.D.
Myelofibrosis: Current and Emerging Treatments
Raajit Rampal, M.D.
10:45 - 11:15 a.m.
Updates on Treatment Approaches for Acute Lymphoblastic Leukemia
Hagop Kantarjian, M.D.
Updates on Treatment Approaches for Acute Lymphoblastic Leukemia
Hagop Kantarjian, M.D.
11:15 - 11:45 a.m.
Improving Outcomes in T-ALL: Challenges and New Directions
Wendy Stock, M.D.
Improving Outcomes in T-ALL: Challenges and New Directions
Wendy Stock, M.D.
1:15 - 1:45 p.m.
Treatment Approaches for Multiple Myeloma in 2022
Paul Richardson, M.D.
Treatment Approaches for Multiple Myeloma in 2022
Paul Richardson, M.D.
1:45 - 2:15 p.m.
Update on BCMA-Directed Therapies for Multiple Myeloma
Adam Cohen, M.D.
Update on BCMA-Directed Therapies for Multiple Myeloma
Adam Cohen, M.D.
2:15 - 2:45 p.m.
Wilms’ Tumor Antigen 1 in Multiple Myeloma
Guenther Koehne, M.D., Ph.D.
Wilms’ Tumor Antigen 1 in Multiple Myeloma
Guenther Koehne, M.D., Ph.D.
2:45 - 3:15 p.m.
Signature Human B-Cell Surface Glycosylation Can Provide Key Insights for Treating B-Cell Malignancies
Charles Dimitroff, Ph.D.
Signature Human B-Cell Surface Glycosylation Can Provide Key Insights for Treating B-Cell Malignancies
Charles Dimitroff, Ph.D.
3:30 - 4:00 p.m.
Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma (DLBCL)
Matthew Matasar, M.D.
Updates on Treatment Approaches in Diffuse Large B-Cell Lymphoma (DLBCL)
Matthew Matasar, M.D.
4:00 - 4:30 p.m.
Updates on Treatment Approaches for Primary (CNS) Lymphoma
Craig Sauter, M.D.
Updates on Treatment Approaches for Primary (CNS) Lymphoma
Craig Sauter, M.D.